The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells

Molecular and Cellular Biology

Volumn 31, Issue 13, 2011, Pages 2683-2695

  Sato, Seiichi ^a   Trackman, Philip C ^b   Mäki, Joni M ^c   Myllyharju, Johanna ^c   Kirsch, Kathrin H ^d   Sonenshein, Gail E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF OULU   (Finland)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN LYSINE 6 OXIDASE; PROTEIN LYSINE 6 OXIDASE PP; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE C RAF; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CELL SURVIVAL; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MITOCHONDRION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MASS SPECTROMETRY; MICE; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-LYSINE 6-OXIDASE; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; RNA, SMALL INTERFERING;

EID: 79959425815     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01148-10     Document Type: Article

References (76)

1. Ballinger, C. A., et al. 1999. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell. Biol. 19:4535-4545.
2. Bausero, M. A., D. T. Page, E. Osinaga, and A. Asea. 2004. Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol. 25:243-251.
3. Becker, T., F. U. Hartl, and F. Wieland. 2002. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158: 1277-1285.
4. Beeram, M., A. Patnaik, and E. K. Rowinsky. 2005. Raf: a strategic target for therapeutic development against cancer. J. Clin. Oncol. 23:6771-6790.
5. Bouez, C., et al. 2006. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model. Clin. Cancer Res. 12:1463-1469.
6. Calderwood, S. K. 2010. Heat shock proteins in breast cancer progression-a suitable case for treatment? Int. J. Hyperthermia 26:681-685.
7. Chen, H., et al. 2006. Hsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination. FEBS Lett. 580:3145-3152.
8. Ciocca, D. R., and S. K. Calderwood. 2005. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86-103.
9. Ciocca, D. R., S. Oesterreich, G. C. Chamness, W. L. McGuire, and S. A. Fuqua. 1993. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J. Natl. Cancer Inst. 85:1558-1570.
10. Contente, S., K. Kenyon, D. Rimoldi, and R. M. Friedman. 1990. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249:796-798.
11. Dai, S., et al. 2010. HSP70 interacts with TRAF2 and differentially regulates TNFalpha signalling in human colon cancer cells. J. Cell. Mol. Med. 14:710- 725.
12. Demand, J., J. Luders, and J. Hohfeld. 1998. The carboxy-terminal domain of Hsc70 provides binding sites for a distinct set of chaperone cofactors. Mol. Cell. Biol. 18:2023-2028.
13. Erler, J. T., et al. 2006. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440:1222-1226.
14. Evans, C. G., L. Chang, and J. E. Gestwicki. 2010. Heat shock protein 70 (hsp70) as an emerging drug target. J. Med. Chem. 53:4585-4602.
15. Galmiche, A., et al. 2008. Isoform-specific interaction of C-RAF with mitochondria. J. Biol. Chem. 283:14857-14866.
16. Gao, T., and A. C. Newton. 2002. The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C. J. Biol. Chem. 277:31585-31592.
17. Gotoh, T., K. Terada, S. Oyadomari, and M. Mori. 2004. hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death Differ. 11:390-402.
18. Guo, S., and G. E. Sonenshein. 2004. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Mol. Cell. Biol. 24:8681-8690.
19. Guo, Y., N. Pischon, A. H. Palamakumbura, and P. C. Trackman. 2007. Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells. Am. J. Physiol. Cell Physiol. 292:C2095-C2102.
20. Ha, J. H., and D. B. McKay. 1995. Kinetics of nucleotide-induced changes in the tryptophan fluorescence of the molecular chaperone Hsc70 and its subfragments suggest the ATP-induced conformational change follows initial ATP binding. Biochemistry 34:11635-11644.
21. Hamalainen, E. R., et al. 1995. Quantitative polymerase chain reaction of lysyl oxidase mRNA in malignantly transformed human cell lines demonstrates that their low lysyl oxidase activity is due to low quantities of its mRNA and low levels of transcription of the respective gene. J. Biol. Chem. 270:21590-21593.
22. Hartl, F. U., and M. Hayer-Hartl. 2009. Converging concepts of protein folding in vitro and in vivo. Nat. Struct. Mol. Biol. 16:574-581.
23. He, J., et al. 2002. Expression of lysyl oxidase gene in upper digestive tract carcinomas and its clinical significance. Ai Zheng 21:671-674. (In Chinese.)
24. Helmbrecht, K., E. Zeise, and L. Rensing. 2000. Chaperones in cell cycle regulation and mitogenic signal transduction: a review. Cell Prolif. 33:341- 365.
25. Hohfeld, J., and S. Jentsch. 1997. GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein BAG-1. EMBO J. 16:6209-6216.
26. Hohfeld, J., Y. Minami, and F. U. Hartl. 1995. Hip, a novel cochaperone involved in the eukaryotic Hsc70/Hsp40 reaction cycle. Cell 83:589-598.
27. Hurtado, P. A., et al. 2008. Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation. Biochem. Biophys. Res. Commun. 366:156- 161.
28. Inoue, A., et al. 1995. 70-kDa heat shock cognate protein interacts directly with the N-terminal region of the retinoblastoma gene product pRb. Identification of a novel region of pRb-mediating protein interaction. J. Biol. Chem. 270:22571-22576.
29. Iosefson, O., and A. Azem. 2010. Reconstitution of the mitochondrial Hsp70 (mortalin)-p53 interaction using purified proteins-identification of additional interacting regions. FEBS Lett. 584:1080-1084.
30. Jeay, S., S. Pianetti, H. M. Kagan, and G. E. Sonenshein. 2003. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. Mol. Cell. Biol. 23:2251-2263.
31. Kagan, H. M., et al. 1995. Expression of lysyl oxidase from cDNA constructs in mammalian cells: the propeptide region is not essential to the folding and secretion of the functional enzyme. J. Cell. Biochem. 59:329-338.
32. Kampinga, H. H., and E. A. Craig. 2010. The HSP70 chaperone machinery: J. proteins as drivers of functional specificity. Nat. Rev. Mol. Cell Biol. 11:579-592.
33. Kaneda, A., et al. 2004. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res. 64:6410-6415.
34. Kardon, J. R., and R. D. Vale. 2009. Regulators of the cytoplasmic dynein motor. Nat. Rev. Mol. Cell Biol. 10:854-865.
35. Kenyon, K., et al. 1991. Lysyl oxidase and rrg messenger RNA. Science 253:802.
36. Kotoglou, P., et al. 2009. Hsp70 translocates to the nuclei and nucleoli, binds to XRCC1 and PARP-1, and protects HeLa cells from single-strand DNA breaks. Cell Stress Chaperones 14:391-406.
37. Lim, J. W., K. H. Kim, and H. Kim. 2008. NF-kappaB p65 regulates nuclear translocation of Ku70 via degradation of heat shock cognate protein 70 in pancreatic acinar AR42J cells. Int. J. Biochem. Cell Biol. 40:2065-2077.
38. Maki, J. M., et al. 2002. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106:2503-2509.
39. Maki, J. M., et al. 2005. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am. J. Pathol. 167:927-936.
40. Martin, J., J. Masri, A. Bernath, R. N. Nishimura, and J. Gera. 2008. Hsp70 associates with Rictor and is required for mTORC2 formation and activity. Biochem. Biophys. Res. Commun. 372:578-583.
41. Mayer, B. J., H. Hirai, and R. Sakai. 1995. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr. Biol. 5:296-305.
42. Michels, A. A., V. T. Nguyen, A. W. Konings, H. H. Kampinga, and O. Bensaude. 1995. Thermostability of a nuclear-targeted luciferase expressed in mammalian cells. Destabilizing influence of the intranuclear microenvironment. Eur. J. Biochem. 234:382-389.
43. Milarski, K. L., and R. I. Morimoto. 1989. Mutational analysis of the human HSP70 protein: distinct domains for nucleolar localization and adenosine triphosphate binding. J. Cell Biol. 109:1947-1962.
44. Min, C., et al. 2007. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res. 67:1105-1112.
45. Min, C., et al. 2009. A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Res. 69:6685-6693.
46. Min, C., et al. 2010. Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis. J. Cell. Biochem. 111:1160- 1168.
47. Morishima, N. 2005. Control of cell fate by Hsp70: more than an evanescent meeting. J. Biochem. 137:449-453.
48. Mosser, D. D., and R. I. Morimoto. 2004. Molecular chaperones and the stress of oncogenesis. Oncogene 23:2907-2918.
49. Niault, T. S., and M. Baccarini. 2010. Targets of Raf in tumorigenesis. Carcinogenesis 31:1165-1174.
50. Nilsson, T., C. E. Au, and J. J. Bergeron. 2009. Sorting out glycosylation enzymes in the Golgi apparatus. FEBS Lett. 583:3764-3769.
51. Palamakumbura, A. H., et al. 2004. The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J. Biol. Chem. 279: 40593-40600.
52. Palamakumbura, A. H., et al. 2009. Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene 28:3390-3400.
53. Park, H. S., et al. 2002. Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 22:7721-7730.
54. Park, H. S., J. S. Lee, S. H. Huh, J. S. Seo, and E. J. Choi. 2001. Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. EMBO J. 20:446-456.
55. Payne, S. L., et al. 2005. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res. 65:11429-11436.
56. Payne, S. L., M. J. Hendrix, and D. A. Kirschmann. 2007. Paradoxical roles for lysyl oxidases in cancer-a prospect. J. Cell. Biochem. 101:1338-1354.
57. Powers, M. V., P. A. Clarke, and P. Workman. 2008. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 14:250-262.
58. Ravagnan, L., et al. 2001. Heat-shock protein 70 antagonizes apoptosisinducing factor. Nat. Cell Biol. 3:839-843.
59. Ren, A., G. Yan, B. You, and J. Sun. 2008. Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells. Cancer Res. 68:2266-2274.
60. Rost, T., et al. 2003. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas. Anticancer Res. 23:1565-1573.
61. Saleh, A., S. M. Srinivasula, L. Balkir, P. D. Robbins, and E. S. Alnemri. 2000. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol. 2:476-483.
62. Seve, S., et al. 2002. Expression analysis of recombinant lysyl oxidase (LOX) in myofibroblastlike cells. Connect. Tissue Res. 43:613-619.
63. Shames, D. S., et al. 2006. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med. 3:e486.
64. Sharda, P. R., C. A. Bonham, E. J. Mucaki, Z. Butt, and P. O. Vacratsis. 2009. The dual-specificity phosphatase hYVH1 interacts with Hsp70 and prevents heat-shock-induced cell death. Biochem. J. 418:391-401.
65. Song, J., M. Takeda, and R. I. Morimoto. 2001. Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nat. Cell Biol. 3:276-282.
66. Takayama, S., J. C. Reed, and S. Homma. 2003. Heat-shock proteins as regulators of apoptosis. Oncogene 22:9041-9047.
67. Thomassin, L., et al. 2005. The Pro-regions of lysyl oxidase and lysyl oxidaselike 1 are required for deposition onto elastic fibers. J. Biol. Chem. 280: 42848-42855.
68. Trackman, P. C., D. Bedell-Hogan, J. Tang, and H. M. Kagan. 1992. Posttranslational glycosylation and proteolytic processing of a lysyl oxidase precursor. J. Biol. Chem. 267:8666-8671.
69. van der Vaart, B., A. Akhmanova, and A. Straube. 2009. Regulation of microtubule dynamic instability. Biochem. Soc. Trans. 37:1007-1013.
70. Vora, S. R., et al. 2010. Characterization of recombinant lysyl oxidase propeptide. Biochemistry 49:2962-2972.
71. Walczak, C. E., S. Cai, and A. Khodjakov. 2010. Mechanisms of chromosome behaviour during mitosis. Nat. Rev. Mol. Cell Biol. 11:91-102.
72. Wilhelm, S. M., et al. 2004. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 64:7099-7109.
73. Wu, M., et al. 2007. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res. 67:6278-6285.
74. Zarrinpar, A., R. P. Bhattacharyya, and W. A. Lim. 2003. The structure and function of proline recognition domains. Sci. STKE 2003:RE8.
75. Zhao, Y., et al. 2009. The lysyl oxidase pro-peptide attenuates fibronectinmediated activation of focal adhesion kinase and p130Cas in breast cancer cells. J. Biol. Chem. 284:1385-1393.
76. Zylicz, M., F. W. King, and A. Wawrzynow. 2001. Hsp70 interactions with the p53 tumour suppressor protein. EMBO J. 20:4634-4638.